C07C 2603/72
Ethanonaphthalenes
Official title: Ethanonaphthalenes; Hydrogenated ethanonaphthalenes
C07C2603/72 (Ethanonaphthalenes) appears on 16 US grants and 13 published applications in this corpus.
Search patents in C07C- Granted patents
- 16
- Published applications
- 13
- Assignees
- 17
- Inventors
- 85
- Latest grant
- 3 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 2 |
| 2006 | 2 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 2 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Radiation-sensitive resin composition, resist pattern-forming method, acid diffusion control agent, carboxylic acid salt and carboxylic acid3 May 2022US 11,320,735 B2Jsr Corporation
- Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders7 Dec 2021US 11,192,849 B2The Trustees of Columbia University in the City of New York
- Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders16 Apr 2019US 10,259,775 B2The Trustees of Columbia University in the City of New York
- Borole compound and organic light-emitting device including the same16 Apr 2019US 10,259,996 B2Samsung Display Co., Ltd.
- Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst29 May 2018US 9,981,977 B2The Regents of the University of California
- Compounds for the Treatment of Neuromuscular Disorders16 Jul 2026US 2026/0199273 A1Nmd Pharma A/S
- Ester compound25 Jan 2024US 2024/0025838 A1Mitsui Chemicals, Inc.
- Radiation-sensitive resin composition, resist pattern-forming method, acid diffusion control agent, carboxylic acid salt and carboxylic acid26 Dec 2019US 2019/0391488 A1Jsr Corporation
- Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders26 Sep 2019US 2019/0292135 A1The Trustees of Columbia University in the City of New York
- Borole compound and organic light-emitting device including the same1 Mar 2018US 2018/0057737 A1Samsung Display Co., Ltd.
Most cited
By later US patents
- Ethanobicyclic amine derivatives for CNS disorders30US 5,089,506 AG. D. Searle & Co. · 1992
- Ethanobicyclic amine derivatives for CNS disorders28US 5,215,992 AG. D. Searle & Co. · 1993
- Sulfamides as gamma-secretase inhibitors19US 7,138,400 B2Merck Sharp & Dohme Corp. · 2006
- Tetrahydroethanonaphthaleneamine derivatives12US 5,202,486 AE. R. Squibb & Sons, Inc. · 1993
- Sulphonamido-substituted bridged bicycloalkyl derivatives5US 7,365,196 B2Merck Frosst Canada, Inc. · 2008